Lactulosum Amara

Lactulose, the active ingredient in Lactulosum Amara, is an osmotic laxative presented as a liquid for oral use. It treats constipation and hepatic encephalopathy in adults. GNH USA supplies Lactulosum Amara as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lactulose is employed to manage conditions that involve impaired bowel motility or excess intestinal ammonia. - Constipation: softens stool and promotes bowel movements through an osmotic effect. - Hepatic encephalopathy: lowers blood ammonia by conversion to lactic and acetic acids, improving neurological symptoms. - Prevention of hepatic encephalopathy recurrence: maintains low ammonia levels in chronic liver disease patients.

Lactulose may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating: sensation of fullness or swelling in the abdomen. - Flatulence: increased intestinal gas production. - Diarrhea: loose, watery stools, especially with higher doses. - Nausea: feeling of sickness or urge to vomit. - Abdominal cramps: painful muscle contractions in the gut. - Thirst: increased desire for fluids.

Serious or Rare Side Effects: - Electrolyte imbalance: abnormal levels of sodium, potassium, or magnesium. - Severe dehydration: marked loss of body fluids. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe abdominal pain: intense, persistent pain requiring medical attention.

When prescribing or dispensing Lactulosum Amara, consider the following safety measures. - Dose adjustment in renal impairment: monitor kidney function and modify dose if needed. - Electrolyte monitoring: check serum electrolytes during prolonged therapy. - Diabetes caution: lactulose may affect glucose control; monitor blood sugar. - Intestinal obstruction: avoid use in patients with known blockage. - Pregnancy and lactation: consult a healthcare professional before use. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Lactulose has limited drug interaction potential, but certain combinations require attention.

Major Interactions (Avoid): - Antibiotics (e.g., rifaximin): may diminish lactulose's ammonia‑lowering effect. - Oral hypoglycemic agents: lactulose can alter glucose absorption, necessitating close monitoring.

Moderate Interactions (Monitor Closely): - Diuretics: increased risk of electrolyte disturbances. - Mineral supplements (calcium, iron): may reduce lactulose absorption. - Probiotics: could modify gut flora and affect efficacy.